Evidence map›Paper›PMID 32104746›Full record

ArticleNanoImpact2020

Prediction of protein corona on nanomaterials by machine learning using novel descriptors.

Yaokai Duan, Roxana Coreas, Yang Liu, Dimitrios Bitounis, Zhenyuan Zhang, Dorsa Parviz, Michael Strano, Philip Demokritou, Wenwan Zhong

Abstract read
In one paragraph

Article in NanoImpact, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Machine Learning-Enhanced Nanoparticle Design for Precision Cancer Drug Delivery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. AI-based Prediction of Protein Corona Composition on DNA Nanostructures.bioRxiv : the preprint server for biology · 2024
    Article
  18. Molecular pharmaceutics · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yaokai DuanDepartment of Chemistry, University of California, Riverside, CA 92507, United States.
Roxana CoreasDepartment of Environmental Toxicology Graduate Program, University of California, Riverside, CA 92507, United States.
Yang LiuDepartment of Environmental Toxicology Graduate Program, University of California, Riverside, CA 92507, United States.
Dimitrios BitounisCenter for Nanotechnology and Nanotoxicology, HSPH-NIEHS Nanosafety Center, Department of Environmental Health, Harvard T. H. Chan School of Public Health, Harvard University, 665 Huntington, Boston, MA 02115, USA.
Zhenyuan ZhangCenter for Nanotechnology and Nanotoxicology, HSPH-NIEHS Nanosafety Center, Department of Environmental Health, Harvard T. H. Chan School of Public Health, Harvard University, 665 Huntington, Boston, MA 02115, USA.
Dorsa ParvizDepartment of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue 66-570b, Cambridge, MA 02139, USA.
Michael StranoDepartment of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue 66-570b, Cambridge, MA 02139, USA.
Philip DemokritouCenter for Nanotechnology and Nanotoxicology, HSPH-NIEHS Nanosafety Center, Department of Environmental Health, Harvard T. H. Chan School of Public Health, Harvard University, 665 Huntington, Boston, MA 02115, USA.
Wenwan ZhongDepartment of Chemistry, University of California, Riverside, CA 92507, United States.

Funding

Research Training in Environmental ToxicologyT32ES018827 · NIEHS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI Yinsheng Wang · 2010 to 2026
$5.3M
Engineered Nanomaterial Synthesis, Characterization and Method Development Center for Nano-safety ResearchU24ES026946 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI DEMOKRITOU, PHILIP · 2016 to 2020
$3.8M
Nano-response: Immune stimulation, microbiome perturbation, and impacts from protein coronaU01ES027293 · NIEHS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI ZHONG, WENWAN · 2016 to 2020
$996k
NIEHS NIH HHS T32 ES018827NIEHS NIH HHS U01 ES027293NIEHS NIH HHS U24 ES026946
6 · The paper itself

Abstract

Effective in silico methods to predict protein corona compositions on engineered nanomaterials (ENMs) could help elucidate the biological outcomes of ENMs in biosystems without the need for conducting lengthy experiments for corona characterization. However, the physicochemical properties of ENMs, used as the descriptors in current modeling methods, are insufficient to represent the complex interactions between ENMs and proteins. Herein, we utilized the fluorescence change (FC) from fluorescamine labeling on a protein, with or without the presence of the ENM, as a novel descriptor of the ENM to build machine learning models for corona formation. FCs were significantly correlated with the abundance of the corresponding proteins in the corona on diverse classes of ENMs, including metal and metal oxides, nanocellulose, and 2D ENMs. Prediction models established by the random forest algorithm using FCs as the ENM descriptors showed better performance than the conventional descriptors, such as ENM size and surface charge, in the prediction of corona formation. Moreover, they were able to predict protein corona formation on ENMs with very heterogeneous properties. We believe this novel descriptor can improve in silico studies of corona formation, leading to a better understanding on the protein adsorption behaviors of diverse ENMs in different biological matrices. Such information is essential for gaining a comprehensive view of how ENMs interact with biological systems in ENM safety and sustainability assessments.

Indexed as

DescriptorENMsMachine learningModelingNanotoxicologyProtein corona

Identifiers

PMID32104746
PMCPMC7043407

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.